{"id":19641,"date":"2024-06-08T17:52:25","date_gmt":"2024-06-08T15:52:25","guid":{"rendered":"https:\/\/www.investincotedazur.com\/?p=19641"},"modified":"2025-08-05T09:57:43","modified_gmt":"2025-08-05T07:57:43","slug":"christophe-mosse-appointed-as-ceo-of-arkopharma-group","status":"publish","type":"post","link":"https:\/\/www.investincotedazur.com\/en\/christophe-mosse-appointed-as-ceo-of-arkopharma-group\/","title":{"rendered":"Christophe Moss\u00e9 appointed as CEO of Arkopharma group"},"content":{"rendered":"\n
\n
\n
\"christophe<\/figure>\n<\/div>\n\n\n\n
\n

Christophe Moss\u00e9 appointed as CEO of Arkopharma group<\/p>\n\n\n\n

He will oversee Arkopharma’s activities and related activities of Dermapharm Group.<\/p>\n\n\n\n

Brings industry expertise from leading groups: Naos, Galderma, Novartis,…<\/p>\n<\/div>\n<\/div>\n\n\n\n

Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.<\/p>\n\n\n\n

Arkopharma, a European leader in its field, has announced the arrival of Christophe Moss\u00e9 as CEO (cf. LinkedIn post below)<\/p>\n\n\n

\n
\"\"<\/a><\/figure><\/div>\n\n\n

Christophe Moss\u00e9 brings a wealth of experience in the pharmaceutical industry, both in France and internationally.<\/p>\n\n\n\n

With his expertise, Christophe Moss\u00e9 will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.<\/p>\n\n\n\n

Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.<\/p>\n\n\n\n

With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n\n\n\n

Health Nice C\u00f4te d’Azur<\/h2>\n\n\n